IRIS
GNECCHI, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.578
AS - Asia 3.503
EU - Europa 3.193
SA - Sud America 467
AF - Africa 53
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 11.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.462
CN - Cina 1.846
IE - Irlanda 818
SG - Singapore 792
IT - Italia 456
HK - Hong Kong 440
RU - Federazione Russa 424
DE - Germania 413
BR - Brasile 396
FI - Finlandia 370
UA - Ucraina 232
VN - Vietnam 152
SE - Svezia 121
GB - Regno Unito 106
CA - Canada 72
FR - Francia 57
IN - India 55
AT - Austria 46
JP - Giappone 43
PL - Polonia 34
MX - Messico 33
BE - Belgio 32
ID - Indonesia 30
AR - Argentina 26
BD - Bangladesh 24
NL - Olanda 22
ES - Italia 21
ZA - Sudafrica 19
TR - Turchia 16
EC - Ecuador 14
IQ - Iraq 13
CO - Colombia 12
AE - Emirati Arabi Uniti 11
PK - Pakistan 10
MU - Mauritius 9
JO - Giordania 8
MY - Malesia 8
AU - Australia 7
KE - Kenya 7
LT - Lituania 7
CZ - Repubblica Ceca 6
IL - Israele 6
PE - Perù 6
AZ - Azerbaigian 5
EU - Europa 5
IR - Iran 5
KG - Kirghizistan 5
KR - Corea 5
SA - Arabia Saudita 5
AL - Albania 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
MA - Marocco 4
PT - Portogallo 4
VE - Venezuela 4
BG - Bulgaria 3
EG - Egitto 3
PA - Panama 3
PS - Palestinian Territory 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
CL - Cile 2
CM - Camerun 2
DZ - Algeria 2
EE - Estonia 2
GI - Gibilterra 2
KZ - Kazakistan 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TW - Taiwan 2
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
PF - Polinesia Francese 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.812
Salva come PNG Salva come JPEG
Città #
Dublin 818
Chandler 686
Hong Kong 438
Beijing 404
Dallas 401
Ashburn 376
Singapore 374
Nanjing 363
Jacksonville 319
Boardman 197
New York 173
Helsinki 159
Wilmington 147
Princeton 145
Los Angeles 143
Lawrence 134
Nanchang 132
Munich 122
Hebei 103
Pavia 101
Changsha 99
Shenyang 95
Medford 92
Jiaxing 86
Shanghai 83
Ann Arbor 76
Moscow 74
Hangzhou 70
Buffalo 57
Ho Chi Minh City 56
Redondo Beach 54
Nuremberg 52
Milan 49
São Paulo 48
Tianjin 45
Turku 43
Toronto 38
Tokyo 36
Hanoi 34
Warsaw 31
Woodbridge 28
Brussels 27
The Dalles 25
Norwalk 23
Dearborn 22
Falls Church 22
Brooklyn 21
Seattle 20
Fairfield 19
Guangzhou 19
Boston 18
Denver 18
Falkenstein 18
Frankfurt am Main 18
Chennai 17
Rio de Janeiro 17
Vienna 17
Belo Horizonte 16
Orem 16
Santa Clara 16
Rome 14
Verona 14
Washington 14
Columbus 13
Montreal 13
Zhengzhou 13
Mexico City 12
Piscataway 12
San Francisco 12
Stockholm 12
Atlanta 11
Chicago 11
Johannesburg 11
Phoenix 11
Poplar 11
Chieti 10
Jakarta 10
London 10
Redwood City 10
Houston 9
Amman 8
Jinan 8
Kunming 8
Ankara 7
Campinas 7
Catanzaro 7
Des Moines 7
Forlì 7
Haiphong 7
Mumbai 7
Palermo 7
Pescara 7
Portsmouth 7
St Petersburg 7
Amsterdam 6
Brasília 6
Caxias do Sul 6
Düsseldorf 6
Manchester 6
Nairobi 6
Totale 7.720
Salva come PNG Salva come JPEG
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 236
Cellule staminali mesenchimali fetali isolate da placenta esercitano effetti paracrini cardioprotettivi. 184
Allogeneic Lethally Irradiated Cord Blood Mononuclear Cells in No-Option Critical Limb Ischemia: A “Box of Rain” 147
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 131
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 126
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 113
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 112
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 112
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 108
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 105
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 104
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 104
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 104
Novel experimental protocol to study area at risk, infarct size, immunohistochemistry and tissue protein content on the same rodent heart. 103
Studio pilota sull'impiego di cellule CD133+ immunoselezionate per il trattamento di vasculopatie periferiche. 102
Adult stem cell-based therapy for the heart 101
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 101
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 101
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 100
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 100
Impiego di cellule staminali mesenchimali in cardiologia. 100
Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia/reoxygenation injury 99
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 99
Mesenchymal stem cell therapy for heart disease. 99
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 99
Paracrine mechanisms of mesenchymal stem cells in tissue repair 98
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 98
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 98
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 97
Gene and cell-based therapies for heart disease 95
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 95
Enhancing stem cell therapy efficacy through genetic modification 94
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 94
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 94
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 93
Cord blood derived endothelial progenitor cells: a superior buiding company in angiogenesis market. 93
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 93
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 92
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 92
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 91
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 91
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 91
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 91
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 91
Cord blood derived endothelial progenitor cells: time dependent in vitro generation capacity. 89
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 89
Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 88
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 88
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 88
MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation 88
Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages 88
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 88
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 87
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 87
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac repair and functional improvement 87
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 87
La contemporanea overespressione di miRNA499 e miRNA133 induce il differenziamento in senso cardiomiocitario di cellule staminali pluripotenti. 85
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 85
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 85
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 85
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 84
microRNA and Cardiac Regeneration 84
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 84
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'? 84
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 83
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 83
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction and conditioned media production 82
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 81
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction 81
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 80
Mesenchymal stem cell therapy for heart disease. 79
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 79
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 79
Cord blood-derived endothelial progenitor cells: a superior building company in the angiogenesis market: P599 79
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 79
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 78
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 77
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future 77
Leptin affects the inflammatory response after STEMI 77
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 77
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries 76
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 76
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 75
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 75
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 74
Endothelium-targeted gene and cell based therapy for cardiovascular disease 73
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 73
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart 73
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 72
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias 72
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 71
First-in-man case of non-invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure 70
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 70
Mesenchymal stem cells overexpressing Akt exhibit enhanced glucose transport and resist hypoxia induced apoptosis 69
Human fetal mesenchymal stem cells exert more powerful cytoprotective paracrine effects than bone marrow-derived mesenchymal stem cells 68
Vascular remodeling in health and disease 67
Long-term clinical outcome after directional coronary atherectomy followed by stem implantation 67
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 67
Stem cell therapy for heart repair: the paracrine paradigm. 66
Donor age negatively influences the cytoprotective paracrine effects exerted by human mesenchymal stem cells 66
Totale 9.092
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.082
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021373 0 0 0 0 0 78 4 90 41 70 70 20
2021/2022588 6 9 26 7 15 23 9 46 45 16 92 294
2022/20232.151 225 155 37 131 207 211 5 116 950 22 55 37
2023/2024953 99 177 33 62 84 270 33 52 6 40 56 41
2024/20252.482 63 173 37 55 79 148 160 162 625 77 312 591
2025/20262.934 498 429 611 580 760 56 0 0 0 0 0 0
Totale 12.034